Sign in
4

Changes in Ownership

Viridian Therapeutics, Inc.\DE Filed Acc 0001104659-26-060294

Director bought 1,176,470 shares at $17.00 ($19,999,990)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Fairmount Funds Management LLC Director 2026-05-11 Purchase +1,176,470 $17.00 $19,999,990 5,090,928 I
Open-market purchases · 1,176,470 sh · avg $17.00 · $19,999,990
Loading xslF345X06/tm2614357-1_4seq1.xml…